Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
06:08:32 18/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 11.17 HKD | -0.89% |
|
-0.45% | -6.68% |
| 04/09 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 03/09 | Simcere Pharmaceutical Group Limited Announces Approval for Marketing of Yingmule in China | CI |
| Market Cap | 3.66B 28.69B 3.19B 3.01B 2.73B 5.12B 351B 5.14B 36.06B 13.92B 178B 13.74B 13.43B 574B | P/E 2026 * |
13.9x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.46B 27.14B 3.02B 2.85B 2.59B 4.85B 332B 4.87B 34.12B 13.17B 169B 12.99B 12.71B 543B | EV / Sales 2026 * |
2.3x | EV / Sales 2027 * | 2.08x |
| Free-Float |
32.13% | Yield 2026 * |
3.78% | Yield 2027 * | 4.29% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | -0.89% | ||
| 1 week | -0.45% | ||
| Current month | +0.63% | ||
| 1 month | -9.70% | ||
| 3 months | +18.33% | ||
| 6 months | -6.99% | ||
| Current year | -6.68% |
| 1 week | 10.92 |  | 11.5 |
| 1 month | 10.92 | | 12.82 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/8/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/7/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/7/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | -0.45% | -14.60% | +69.50% | 3.69B | |
| -1.61% | -1.27% | +13.40% | +59.79% | 46.78B | |
| -1.02% | -3.01% | +36.66% | +100.50% | 37.88B | |
| +2.19% | +3.78% | +12.21% | +79.75% | 11.82B | |
| +1.32% | +1.54% | -10.59% | +12.87% | 11.61B | |
| -0.95% | -0.38% | +17.65% | +146.45% | 9.12B | |
| +0.39% | +2.39% | +29.99% | +38.63% | 7.38B | |
| +1.30% | +1.34% | +19.83% | +185.74% | 7.12B | |
| -0.06% | +1.94% | +39.71% | -18.67% | 7.21B | |
| +0.70% | -2.06% | -42.22% | +7.42% | 4.99B | |
| Average | +0.14% | +0.45% | +10.20% | +68.20% | 14.76B | |
| Weighted average by Cap. | -0.47% | -0.08% | +17.49% | +73.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 11.78B 1.31B 1.24B 1.12B 2.1B 144B 2.11B 14.81B 5.72B 73.25B 5.64B 5.52B 236B | 1.69B 13.28B 1.48B 1.39B 1.27B 2.37B 162B 2.38B 16.69B 6.44B 82.57B 6.36B 6.22B 266B |
| Net income | 255M 2B 223M 210M 191M 358M 24.5B 359M 2.52B 972M 12.46B 959M 938M 40.08B | 302M 2.37B 263M 248M 226M 423M 28.96B 424M 2.98B 1.15B 14.72B 1.13B 1.11B 47.37B |
| Net Debt | -197M -1.55B -172M -162M -148M -276M -18.93B -278M -1.95B -751M -9.63B -741M -725M -30.97B | -140M -1.1B -122M -115M -104M -196M -13.41B -197M -1.38B -532M -6.82B -525M -513M -21.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | HKD 11.17 | -0.89% | 12,393,000 |
| 17/09/26 | HKD 11.27 | +0.90% | 2,608,472 |
| 16/09/26 | HKD 11.17 | -0.71% | 2,716,666 |
| 15/09/26 | HKD 11.25 | -1.23% | 2,323,000 |
| 14/09/26 | HKD 11.39 | +3.08% | 7,211,232 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
